CN112206093A - 防水透气湿式敷料 - Google Patents
防水透气湿式敷料 Download PDFInfo
- Publication number
- CN112206093A CN112206093A CN201910618556.XA CN201910618556A CN112206093A CN 112206093 A CN112206093 A CN 112206093A CN 201910618556 A CN201910618556 A CN 201910618556A CN 112206093 A CN112206093 A CN 112206093A
- Authority
- CN
- China
- Prior art keywords
- dressing
- waterproof breathable
- wet dressing
- factor
- tattoo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012423 maintenance Methods 0.000 claims abstract description 7
- 239000010408 film Substances 0.000 claims description 31
- 239000000017 hydrogel Substances 0.000 claims description 30
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 18
- 230000003020 moisturizing effect Effects 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- 235000011399 aloe vera Nutrition 0.000 claims description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 10
- 229920002674 hyaluronan Polymers 0.000 claims description 10
- 229960003160 hyaluronic acid Drugs 0.000 claims description 10
- 235000010443 alginic acid Nutrition 0.000 claims description 9
- 229920000615 alginic acid Polymers 0.000 claims description 9
- 229960000271 arbutin Drugs 0.000 claims description 9
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 9
- -1 silver ions Chemical class 0.000 claims description 9
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 7
- 230000001070 adhesive effect Effects 0.000 claims description 7
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 7
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 6
- 244000144927 Aloe barbadensis Species 0.000 claims description 6
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 6
- 102000004127 Cytokines Human genes 0.000 claims description 6
- 108090000695 Cytokines Proteins 0.000 claims description 6
- 206010039509 Scab Diseases 0.000 claims description 6
- 229940072056 alginate Drugs 0.000 claims description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 6
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000416 hydrocolloid Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 5
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 5
- 235000017803 cinnamon Nutrition 0.000 claims description 5
- 238000011161 development Methods 0.000 claims description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 4
- 241000723346 Cinnamomum camphora Species 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 244000163122 Curcuma domestica Species 0.000 claims description 4
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 4
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 4
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 4
- 229920002079 Ellagic acid Polymers 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 239000005844 Thymol Substances 0.000 claims description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 4
- 229940116229 borneol Drugs 0.000 claims description 4
- 229930008380 camphor Natural products 0.000 claims description 4
- 229960000846 camphor Drugs 0.000 claims description 4
- 229960002504 capsaicin Drugs 0.000 claims description 4
- 239000010634 clove oil Substances 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 235000003373 curcuma longa Nutrition 0.000 claims description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 4
- 229960002852 ellagic acid Drugs 0.000 claims description 4
- 235000004132 ellagic acid Nutrition 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 4
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 4
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 4
- 229960004705 kojic acid Drugs 0.000 claims description 4
- 229940041616 menthol Drugs 0.000 claims description 4
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 4
- 229960000790 thymol Drugs 0.000 claims description 4
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 4
- 229960000401 tranexamic acid Drugs 0.000 claims description 4
- 235000013976 turmeric Nutrition 0.000 claims description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 3
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 3
- 241000402754 Erythranthe moschata Species 0.000 claims description 3
- 239000004863 Frankincense Substances 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 240000003553 Leptospermum scoparium Species 0.000 claims description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 3
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 3
- 229960000458 allantoin Drugs 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 229950004580 benzyl nicotinate Drugs 0.000 claims description 3
- 235000017663 capsaicin Nutrition 0.000 claims description 3
- 229940106189 ceramide Drugs 0.000 claims description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 3
- 229940119217 chamomile extract Drugs 0.000 claims description 3
- 235000020221 chamomile extract Nutrition 0.000 claims description 3
- 229960005188 collagen Drugs 0.000 claims description 3
- 229960001193 diclofenac sodium Drugs 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 229940014259 gelatin Drugs 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 3
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 3
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 3
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 claims description 3
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- 244000061520 Angelica archangelica Species 0.000 claims 2
- 235000003717 Boswellia sacra Nutrition 0.000 claims 2
- 240000007551 Boswellia serrata Species 0.000 claims 2
- 235000012035 Boswellia serrata Nutrition 0.000 claims 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 2
- 244000004281 Eucalyptus maculata Species 0.000 claims 2
- 244000028344 Primula vulgaris Species 0.000 claims 2
- 235000016311 Primula vulgaris Nutrition 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 229930003268 Vitamin C Natural products 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- 239000000741 silica gel Substances 0.000 claims 2
- 229910002027 silica gel Inorganic materials 0.000 claims 2
- 235000019154 vitamin C Nutrition 0.000 claims 2
- 239000011718 vitamin C Substances 0.000 claims 2
- 206010052428 Wound Diseases 0.000 abstract description 37
- 208000027418 Wounds and injury Diseases 0.000 abstract description 35
- 230000029663 wound healing Effects 0.000 abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000000740 bleeding effect Effects 0.000 description 9
- 238000002955 isolation Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- 239000007921 spray Substances 0.000 description 7
- 210000000416 exudates and transudate Anatomy 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000002633 protecting effect Effects 0.000 description 6
- 241001116389 Aloe Species 0.000 description 5
- 230000002040 relaxant effect Effects 0.000 description 5
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000006748 scratching Methods 0.000 description 3
- 230000002393 scratching effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 230000037314 wound repair Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- BTLDCKUVQBCAHK-UHFFFAOYSA-N [K].COOC=1C(C(=O)O)=CC=CC1 Chemical compound [K].COOC=1C(C(=O)O)=CC=CC1 BTLDCKUVQBCAHK-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- LEQPDRCDFUVPNF-UHFFFAOYSA-N methyl prop-2-enoate;potassium Chemical class [K].COC(=O)C=C LEQPDRCDFUVPNF-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- FRMWBRPWYBNAFB-UHFFFAOYSA-M potassium salicylate Chemical compound [K+].OC1=CC=CC=C1C([O-])=O FRMWBRPWYBNAFB-UHFFFAOYSA-M 0.000 description 1
- 229960003629 potassium salicylate Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01012—Non-adhesive bandages or dressings characterised by the material being made of natural material, e.g. cellulose-, protein-, collagen-based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
- A61F13/0243—Adhesive bandages or dressings wound covering film layers without a fluid retention layer characterised by the properties of the skin contacting layer, e.g. air-vapor permeability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01046—Air-vapor permeability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开一种具有加速伤口愈合及滋润护色的防水透气湿式敷料,用于新鲜刺青后的伤口修复与护色保养,本发明可提供刺青后专业医疗级修护、减少伤口出血、渗液及墨水渗出,缓和不舒服的情绪,提升刺青艺术美感。
Description
技术领域
本发明是以具加速伤口愈合及滋润护色的防水透气湿式敷料,用于新鲜刺青后的伤口修复与护色保养,本发明可提供刺青后专业医疗级修护、减少伤口出血、渗液及墨水渗出,缓和不舒服的情绪,提升刺青艺术美感。
背景技术
近年来刺青已从以往的次文化跃升为流行文化。随着刺青人数的增加,刺青伤口保养的问题亦开始受到重视。以往新鲜刺青后伤口保持通风透气为主要护理原则,因此会仅涂抹凡士林或者纹身专用药膏进行保湿而不贴任何敷料。
然而,仅涂抹凡士林或者纹身专用药膏并不能完全隔离伤口,甚至容易沾到衣物,导致不便与不适,亦造成需要不断补药的状况。而刺青的伤口为开放性伤口,在不受隔离的情况下,若是碰到水(如洗澡)、接触到空气中或衣物的细菌,都可能造成伤口感染导致发炎或刺青墨水渗出损失。另外,若无隔离层,伤口结痂时容易被棉被、床铺、毛巾、衣裤沾到而将痂勾下来,使伤口再度裂开,造成感染或褪色。另外,伤口在不被隔离的情况下,患者容易因为干燥造成的搔痒感而抓痒伤口,亦造成感染或褪色,这种墨水损失反而降低刺青或纹身的技术质量和视觉美观。
为此,目前为了保护新鲜刺青造成的伤口,刺青师会使用石化塑料(如保鲜膜)作为闭塞层及辅助敷料,通常不具医疗级质量。这些家用保鲜膜材料,不吸收伤口渗出液,包裹在皮肤周围形成密闭,将伤口渗液及渗出墨水包覆在里面,避免刺青后的组织渗液及墨水沾黏至衣物上,同时亦减少伤口摩擦。
然而,保鲜膜非透气材质,而不透气及过湿容易造成伤口溃烂,因此保鲜膜仅作为新鲜刺青后三小时内的闭塞层,三小时后则必须去除保鲜膜。保鲜膜除了使伤口闷湿不适且容易感染,亦容易脱落。
以往新鲜刺青后并未被视为医疗行为,刺青伤口几乎不被视为正式术后的开放性伤口处理,因此不会使用敷料防护,造成刺青伤口愈合感染的风险,刺青因伤口愈合问题及墨水散失的因素,导致掉色、暗沉、留疤或生活行动不便是非常不希望的。
为此,近年来推出一项针对刺青的水凝胶敷料,如,美国专利公告号第US20140200196A1、US09649330B2号的专利及PCT公告号第WO2014145714A1号的专利揭示以藻酸盐的水凝胶结合含矿物的喷雾溶液形成透明薄膜层做伤口隔离并帮助伤口止血与修复;但因其水凝胶仍呈现凝胶状,结构力不足,无法缓冲伤口部位的物理撞击及摩擦。
另外,该专利涉及两种材料,其一是藻酸盐类的水凝胶,其二是含矿物的喷雾溶液。其水凝胶的作用以湿润疗创的原理促进伤口修复,以及透过内含的止血因子促进伤口止血。然而该水凝胶材质因外层薄膜材质不防水,使得水分挥发造成凝胶因干燥而脱落,且无法在无伤口渗液状态下的伤口使用。因此,该敷料与保鲜膜类似,只能在刺青结束后三小时内使用,三小时后的保养修护,不适合使用该敷料。
其含矿物的喷雾溶液形成的薄膜作用为隔离,防止感染。然而该薄膜不具有防水的作用,也无足够的黏着度。不具防水作用,使得新鲜刺青后伤口不能碰到水,如洗澡、清洁、雨天外出…等,否则水凝胶的膨胀会造成敷料脱落。而无足够的黏着度使得患者必须避免伤口处的敷料与衣物的摩擦,亦不可再感到搔痒时摩擦或拍打伤口,造成患者不必要的痛苦与生活行动的不便。
此外,该专利涉及两步骤,步骤一是先涂抹一层薄薄的水凝胶,步骤二是在特定距离下喷洒含矿物的喷雾溶液,使喷雾凝结后在水凝胶表面上形成薄膜,可见过程复杂麻烦。若能以片材取代,即可减少步骤以及注意事项,降低复杂度及麻烦程度。
因此,如何帮助新鲜刺青后的伤口修复和护色美观,是目前业界需解决的问题。
发明内容
为解决上述问题,亟需开发既能促进伤口愈合、降低出血渗液及刺青墨水渗出,保持肌肤微润不干固、增强刺青颜色视觉艺术的敷料。本研究提供一种防水透气湿式敷料的用途,其包含防水透气薄膜,该防水透气湿式敷料能促进伤口愈合、具防水透气、隔离保护及缓冲外在环境刺激、保持肌肤湿润、降低结痂搔痒、维护刺青图案等功效。
在本发明之一的实施例中,所述湿式敷料包含防水透气薄膜,所述防水透气薄膜包含片状型透明薄膜(Films)、水凝胶(hydrogel)、水胶体(Hydrocolloid)、亲水性纤维(Hydrofiber)、藻酸盐(Alginates,海藻酸钠)、银离子(Silver)、硅胶(Silicone)、壳聚糖(Chitosan)、生物敷料(Biological)或液态之喷剂型薄膜敷料(Spray dressing)。
在本发明之一的实施例中,所述的防水透气薄膜包含舒缓因子或润色因子,所述舒缓因子或所述润色因子可选择性存在于所述防水透气薄膜中,其中所述舒缓因子或润色因子,是指提高舒适度、帮助伤口愈合、及护色显色等保养中的一种或多种。
在本发明之一的实施例中,所述防水透气薄膜,其中所述舒缓因子,能促进伤口愈合及提高舒适度如抑菌、抗感染、止血、促进愈合、避免结痂、止痒、止痛、消炎、消肿、舒缓镇定、减少伤口异味等,选自胶原蛋白、透明质酸、甘油、神经酰胺、明胶、生长因子、细胞因子(cytokine)、藻酸盐、银离子、抗菌胜肽、几丁聚糖、双氯芬酸钠(Diclofenac Sodium)、引朵美洒辛(Indomethacin)、薄荷脑(Menthol)、樟脑(Camphor)、百里香酚(Thymol)、茶树精油(TeaTree Oil)、丁香油(Clove oil)、冰片(Borneol)、辣椒素(Capsaicin)、烟酸苄酯(Nicotinic acid benzyl ester)、尤加利精油(Eucalyptus oil)、姜黄(Curcumin)、麝香(musk)、肉桂(Cinnamon)、当归(Angelica)、及乳香(Frankincense)及其衍生物中的一种或多种。
在本发明之一的实施例中,所述的防水透气薄膜,其中所述润色因子,能滋润护色,如保湿、艳色、润色、美白等,选自甘草酸(Glycyrretinic acid)、丹参(Salviamiltiorrhiza)、尿囊素(Allantoin)、芦荟(Aloe)、熊果素(Arbutin)、维生素C(Ascorbyl)、水杨酸(Salicylic acid)、鞣花酸(Ellagic Acid)、曲酸(Kojic Acid)、洋甘菊萃取物(Chamomile ET)、传明酸(Tranexamic Acid)、二丙基联苯二醇(5,5’-Drpropyl-Biphenyl-2,2’-diol)及其衍生物中的一种或多种。
在本发明之一的实施例中,所述的防水透气薄膜,其中所述舒缓因子或润色因子,占所述湿式敷料重量的百分比为0.01~10%。
在本发明之一的实施例中,所述的防水透气薄膜,其中所述舒缓因子或润色因子具保湿护色功效,包含0.5%甲氧基水杨酸钾酸(Potassium Methoxysalicylate)或2%芦荟(Aloe)。
在本发明之一的实施例中,所述的防水透气薄膜,其中所述舒缓因子或润色因子具保湿护色功效,包含0.5g熊果素或0.1g透明质酸。
在本发明之一的实施例中,所述的防水透气湿式敷料,其中包含防水透气薄膜和水凝胶,所述水凝胶是指提高舒适度、帮助伤口愈合、保护隔离、缓冲结构、防水透气、湿润平衡、锁水润色及等保养功效中的一种或多种。
本发明是提供刺青专用敷料,使新鲜刺青伤口具医疗级修护及专业艺术美感呈现;保护隔离不感染,不受衣物、棉被等日常接触物品沾黏摩擦、防水透气降低伤口溃烂、洗澡不便性及墨水稀释散逸、滋润护色帮助颜料色彩附着及不结痂,完美展现刺青艺术的视觉美感。
附图说明
图1为涂抹舒缓因子或润色因子于刺青处的示意图。
图2为涂抹舒缓因子或润色因子后使用黏贴湿式敷料于刺青处的示意图。
图3为防水透气湿式敷料的侧面结构示意图。
附图标记说明
10、湿式敷料;101、刺青;102、舒缓因子;103、润色因子;20、防水透气湿式敷料;201、防水透气薄膜;202、水凝胶。
具体实施方式
兹就本申请案的操作方式举数个实施例,并配合图示说明描述于后,使提供审查参阅。再者,本发明中的图示,为便于说明,其比例及位置未必按照实际比例绘制,图标中的比例与位置并不用以限制本发明所请求保护的范围。
下述范例具非局限性,且仅代表本发明的数个方面及特性。
实施例1
先用清洁干净冷水,以纱布轻轻清除新鲜刺青处的出血、渗液、墨水等物质,用至少大于刺青周围0.5cm,具促进伤口愈合、保护隔离、缓冲结构、防水透气、吸组织液保湿的水胶体敷料(湿式敷料10),轻轻黏贴在该处,每0.5~2天更换(视出血及渗液多寡调整更换频率),并重复上述步骤直到伤口愈合。
实施例2
如图1、2,先用清洁干净冷水,以纱布轻轻清除新鲜刺青处的出血、渗液、墨水等物质,提供润色因子103含0.5%甲氧基水杨酸钾酸(Potassium Methoxysalicylate)或2%芦荟(Aloe)的溶液,待其留存微湿状态后,再将至少大于刺青周围0.5cm,具促进伤口愈合、保护隔离、缓冲结构、防水透气、吸组织液保湿的水胶体敷料(湿式敷料10),轻轻黏贴在该处,每0.5~2天更换(视出血及渗液多寡调整更换频率),并重复上述步骤。
如图2,本实施例提供一种湿式敷料10含润色因子103为0.5%甲氧基水杨酸钾酸(Potassium Methoxysalicylate)或2%芦荟(Aloe),该刺青101为身体皮肤的部位,并将湿式敷料10覆盖刺青处101,促进伤口愈合、保护隔离、缓冲、防水透气及吸组织液保湿。
实施例3
将含水量大于50%的水凝胶202与防水透气薄膜201相结合,形成周围具自黏性、促进伤口愈合、保护隔离、缓冲结构、防水透气、湿润平衡、锁水润色的防水透气湿式敷料20;用清洁干净冷水,以纱布轻轻清除新鲜刺青处的出血、渗液、墨水等物质,将此防水透气湿式敷料20黏贴于新鲜刺青处101,每0.5~2天更换(视出血及渗液多寡调整更换频率)。
如图3,其为本发明的防水透气湿式敷料20的侧面结构示意图,所述防水透气湿式敷料20包含防水透气薄膜201以及水凝胶202,其中所述防水透气湿式敷料20具有两面结构,其中一面为黏合面(黏合面未示出),该黏合面上具有黏合剂,所述黏合面会与所述水凝胶202黏合,以使所述防水透气薄膜201以及所述水凝胶202组成所述防水透气湿式敷料20。此外,所述防水透气薄膜201的表面积大于所述水凝胶202的表面积,因此所述防水透气薄膜201的黏合面会有多出黏合所述水凝胶202外的黏合面积,用以提供所述防水透气湿式敷料20与肌肤的黏合,而肌肤黏合区域为供氧和湿气交换又防水的密封环境,隔绝微生物与污染物进入伤口,以促进黏合区肌肤于湿润而不过度浸润或干燥现象。
实施例4
提供舒缓因子102为0.1g透明质酸和润色因子103为0.5g熊果素加入99g水凝胶中,形成含水量大于50%,透明质酸浓度0.1%的熊果素水凝胶,再将此具缓释熊果素/透明质酸的水凝胶与实施例3的防水透气薄膜201相结合,形成周围具自黏性、促进伤口愈合、保护隔离、缓冲结构、防水透气、湿润平衡、锁水润色、艳泽显色的防水透气湿式敷料20;用清洁干净冷水,以纱布轻轻清除新鲜刺青处的出血、渗液、墨水等物质,将此防水透气湿式敷料轻轻黏贴于新鲜刺青处,每0.5~2天更换一次(视出血及渗液多寡调整更换频率)。
将上述不同实施例与目前刺青业界常用的保鲜膜(作为比较例)各找5人在新鲜刺青后进行修护测试,分别测量其对于刺青伤口修护的指标,其测试结果如表1所示。
表1、20名新鲜刺青者依本发明所述的实施例与比较例的测试结果(状况分级:★★★最佳、★★☆次佳、★★佳、★☆普通、★较差、☆趋近无效、━无效)
本发明中所述的“银离子”具抑制菌繁殖生长或杀菌功效。
上述实施例仅为例示性说明本发明的功效,并阐述本发明的技术特征,而非用于限制本发明的保护范畴。任何熟悉本技术者在不违背本发明的技术原理及精神下,可轻易完成的改变或安排,均属本发明所主张的范围。因此,本发明的权利保护范围如前述权利要求书所列。
Claims (13)
1.一种湿式敷料的用途,用于刺青后护色显色保养,包含防水透气薄膜,其特征是,所述防水透气薄膜包含片状型透明薄膜、水凝胶、水胶体、亲水性纤维、藻酸盐、银离子、硅胶、壳聚醣、生物敷料或液态的喷剂型薄膜敷料;
其中,所述湿式敷料可贴附于刺青图腾上,可以使刺青图腾在伤口愈合时避免伤口结痂、减缓不适并保持刺青图腾艳色和润色效果。
2.如权利要求1所述的用途,其特征是,所述湿式敷料包含舒缓因子或润色因子。
3.如权利要求2所述的用途,其特征是,所述舒缓因子选自胶原蛋白、透明质酸、甘油、神经酰胺、明胶、生长因子、细胞因子、藻酸盐、银离子、抗菌胜肽、几丁聚糖、双氯芬酸钠、引朵美洒辛、薄荷脑、樟脑、百里香酚、茶树精油、丁香油、冰片、辣椒素、烟酸苄酯、尤加利精油、姜黄、麝香、肉桂、当归、及乳香及其衍生物中的一种或多种。
4.如权利要求2所述的用途,其特征是,所述润色因子选自甘草酸、丹参、尿囊素、芦荟、熊果素、维生素C、水杨酸、鞣花酸、曲酸、洋甘菊萃取物、传明酸、二丙基联苯二醇及其衍生物中的一种或多种。
5.如权利要求2所述的用途,其特征是,所述舒缓因子或所述润色因子,占所述湿式敷料重量的百分比为0.01~10%。
6.如权利要求2所述的用途,其特征是,所述润色因子包含0.5%甲氧基水杨酸钾酸或2%芦荟。
7.如权利要求2所述的用途,其特征是,所述润色因子包含0.5g熊果素或0.1g透明质酸。
8.一种防水透气湿式敷料,其特征是,包含:
防水透气薄膜,所述防水透气薄膜具有黏合面;
水凝胶,所述水凝胶的一个表面结合所述防水透气薄膜的黏合面,所述水凝胶另一相对表面与皮肤贴附;
其中,所述防水透气湿式敷料可贴附于刺青图腾上,可以使刺青图腾在伤口愈合时避免伤口结痂、减缓不适并保持刺青图腾艳色和润色效果。
9.如权利要求8所述的防水透气湿式敷料,其特征是,所述防水透气湿式敷料包含舒缓因子或润色因子。
10.如权利要求9所述的防水透气湿式敷料,其特征是,所述舒缓因子选自胶原蛋白、透明质酸、甘油、神经酰胺、明胶、生长因子、细胞因子、藻酸盐、银离子、抗菌胜肽、几丁聚糖、双氯芬酸钠、引朵美洒辛、薄荷脑、樟脑、百里香酚、茶树精油、丁香油、冰片、辣椒素、烟酸苄酯、尤加利精油、姜黄、麝香、肉桂、当归、及乳香及其衍生物中的一种或多种。
11.如权利要求9所述的防水透气湿式敷料,其特征是,所述润色因子选自甘草酸、丹参、尿囊素、芦荟、熊果素、维生素C、水杨酸、鞣花酸、曲酸、洋甘菊萃取物、传明酸、二丙基联苯二醇及其衍生物中的一种或多种。
12.一种如权利要求8所述的防水透气湿式敷料的用途,用于刺青后护色显色保养,其特征是,所述防水透气湿式敷料包含水凝胶、水胶体、亲水性纤维、藻酸盐、银离子、硅胶、壳聚醣、生物敷料或薄膜敷料。
13.如权利要求12所述的用途,其特征是,所述防水透气湿式敷料选自片状型或液态的喷剂型。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910618556.XA CN112206093A (zh) | 2019-07-10 | 2019-07-10 | 防水透气湿式敷料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910618556.XA CN112206093A (zh) | 2019-07-10 | 2019-07-10 | 防水透气湿式敷料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112206093A true CN112206093A (zh) | 2021-01-12 |
Family
ID=74047037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910618556.XA Pending CN112206093A (zh) | 2019-07-10 | 2019-07-10 | 防水透气湿式敷料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112206093A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022226857A1 (zh) * | 2021-04-29 | 2022-11-03 | 美丽康生技股份有限公司 | 一种用于刺青护色的湿式敷料及其使用方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273128A (zh) * | 1999-08-12 | 2000-11-15 | 中国原子能科学研究院 | 水凝胶复合型创伤敷料及其辐射合成方法 |
US20040127838A1 (en) * | 2002-08-16 | 2004-07-01 | Inkslingers, Inc. | Article, system, and method of covering and protecting portions of human skin |
CN101781530A (zh) * | 2010-01-29 | 2010-07-21 | 抚州市临川之信生物科技有限公司 | 一种不干胶纹身贴纸及其制备方法 |
US20140200196A1 (en) * | 2013-01-17 | 2014-07-17 | Thomas Barrows | Hydrogel Tattoo Protection and Aftercare System |
CN104841008A (zh) * | 2015-06-11 | 2015-08-19 | 傅兴琴 | 一种水凝胶敷料及其制备方法 |
CN204671391U (zh) * | 2015-05-18 | 2015-09-30 | 广东泰宝医疗科技股份有限公司 | 一种水凝胶泡沫敷料 |
CN105078651A (zh) * | 2015-08-14 | 2015-11-25 | 上海典范医疗科技有限公司 | 多功能湿性医用伤口敷料及其制备方法 |
-
2019
- 2019-07-10 CN CN201910618556.XA patent/CN112206093A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273128A (zh) * | 1999-08-12 | 2000-11-15 | 中国原子能科学研究院 | 水凝胶复合型创伤敷料及其辐射合成方法 |
US20040127838A1 (en) * | 2002-08-16 | 2004-07-01 | Inkslingers, Inc. | Article, system, and method of covering and protecting portions of human skin |
CN101781530A (zh) * | 2010-01-29 | 2010-07-21 | 抚州市临川之信生物科技有限公司 | 一种不干胶纹身贴纸及其制备方法 |
US20140200196A1 (en) * | 2013-01-17 | 2014-07-17 | Thomas Barrows | Hydrogel Tattoo Protection and Aftercare System |
CN204671391U (zh) * | 2015-05-18 | 2015-09-30 | 广东泰宝医疗科技股份有限公司 | 一种水凝胶泡沫敷料 |
CN104841008A (zh) * | 2015-06-11 | 2015-08-19 | 傅兴琴 | 一种水凝胶敷料及其制备方法 |
CN105078651A (zh) * | 2015-08-14 | 2015-11-25 | 上海典范医疗科技有限公司 | 多功能湿性医用伤口敷料及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022226857A1 (zh) * | 2021-04-29 | 2022-11-03 | 美丽康生技股份有限公司 | 一种用于刺青护色的湿式敷料及其使用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2441375T3 (es) | Parche para el tratamiento del herpes labial | |
WO2015135351A1 (zh) | 吸液性创面可观察的伤口敷料 | |
RU2711863C2 (ru) | Система двухкомпонентной раневой повязки | |
ES2546780T3 (es) | Parche adhesivo | |
RU2704601C2 (ru) | Система раневой повязки | |
EP3763396A1 (en) | Method for color maintenance and enhancement of tattoo | |
JP6147874B2 (ja) | 皮膚マスキング材 | |
JP6290184B2 (ja) | 創傷ドレッシング | |
KR20100009549U (ko) | 자외선차단용 상처치유밴드 | |
CN112206093A (zh) | 防水透气湿式敷料 | |
CN208808841U (zh) | 一种复合型网面医用敷料 | |
CN209450778U (zh) | 一种抑制疤痕的复合型敷料 | |
CN211095264U (zh) | 一种用于乳腺肿物微创手术的碘伏防水敷料 | |
CN210019926U (zh) | 一种抑制瘢痕的可吸收降解敷料 | |
CN202458908U (zh) | 新型创可贴 | |
WO2022226857A1 (zh) | 一种用于刺青护色的湿式敷料及其使用方法 | |
CN112545756A (zh) | 一种医用臭氧油-硅酮泡沫敷贴的制备方法 | |
CN219354798U (zh) | 一种敷料装置 | |
CN222091969U (zh) | 一种医用无菌敷贴组件 | |
US20200315857A1 (en) | Pasting structure | |
CN220193343U (zh) | 一种双药贴式创口贴 | |
CN209884516U (zh) | 一种透明海藻酸盐伤口愈合贴 | |
CN219461672U (zh) | 适用于褥疮治疗的复合型新型敷料 | |
CN209059667U (zh) | 一种贴覆结构 | |
CN209450779U (zh) | 一种抑制疤痕的润肤敷料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210112 |